Claudia Augusta Di Trani

发表

Specific Protein 1 and p53 Interplay Modulates the Expression of the KCTD-Containing Cullin3 Adaptor Suppressor of Hedgehog 2

G. Canettieri, E. Ferretti, E. De Smaele, 2021, Frontiers in Cell and Developmental Biology.

Novel strategies exploiting interleukin-12 in cancer immunotherapy.

I. Melero, P. Berraondo, E. Castañón, 2022, Pharmacology & therapeutics.

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications

I. Melero, P. Berraondo, Á. Teijeira, 2021, Cancers.

Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity

F. Corrales, P. Berraondo, S. Ciordia, 2021, Frontiers in Immunology.

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

I. Melero, P. Berraondo, H. Hochrein, 2022, Oncoimmunology.

Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

I. Melero, P. Berraondo, Á. Teijeira, 2022, Oncoimmunology.

Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α

P. Berraondo, J. Lasarte, N. Casares, 2019, The Journal of Immunology.

Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors

I. Melero, P. Berraondo, Fernando Aranda, 2021, Journal for ImmunoTherapy of Cancer.

Advances in mRNA-based drug discovery in cancer immunotherapy

I. Melero, P. Berraondo, Irene Olivera, 2021, Expert opinion on drug discovery.

Intratumoral gene transfer of mRNAs encoding interleukin-12 in combination with decoy-resistant interleukin-18 improves local and systemic antitumor immunity.

I. Melero, P. Berraondo, C. D. de Andrea, 2022, Cancer immunology research.

Interleukin-12 Message in a Bottle

I. Melero, P. Berraondo, A. Cirella, 2020, Clinical Cancer Research.

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

N. Tennagels, P. Berraondo, J. Escalada, 2021, Frontiers in Pharmacology.

Overcoming the limitations of cytokines to improve cancer therapy.

I. Melero, P. Berraondo, Fernando Aranda, 2022, International review of cell and molecular biology.

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

I. Melero, P. Berraondo, Á. Teijeira, 2023, Molecular therapy. Nucleic acids.

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

I. Melero, P. Berraondo, A. van Elsas, 2023, Molecular therapy. Nucleic acids.

Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

P. Berraondo, H. Lauterbach, Claudia Augusta Di Trani, 2024, Journal for ImmunoTherapy of Cancer.